EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Targeting the PI3K/Akt/NF‐κB axis: Cluster of differentiation 5‐like‐mediated immunometabolic regulation of macrophage polarization in abdominal aortic aneurysm

Hemoren Yi, Nan Liu, Zhengyang Wu, Lei Li, Tingting Li, Qixiang Liu, Man Duan, Taihu Wan

Journal of Cell Communication and Signaling · 2025-12 · 19 (4)

DOI: 10.1002/ccs3.70048 ↗
AbstractBibliografische Angaben

Abstract

Abstract Abdominal aortic aneurysm (AAA) is a life‐threatening vascular disorder lacking effective pharmacological interventions. We identified CD5 molecule‐like (CD5L) as a regulator of macrophage polarization in AAA via the phosphoinositide 3‐kinase/protein kinase B/nuclear factor kappa B (PI3K/Akt/NF‐κB) pathway. Transcriptomic analyses (GSE47472 and GSE57691) and angiotensin II (AngII)‐infused apolipoprotein E‐deficient (ApoE −/− ) mice showed CD5L upregulation, inversely correlated with M1 macrophage infiltration. In vitro CD5L overexpression reduced, whereas knockdown increased M1 polarization and pro‐inflammatory cytokines in RAW264.7 cells and human monocyte‐derived macrophages. In vivo, CD5L knockdown aggravated aortic dilation, vascular disruption, and inflammatory mediator expression. Pharmacological modulation confirmed PI3K/Akt as essential for CD5L's anti‐inflammatory action: LY294002 amplified, whereas PI3K activator 740Y‐P mitigated CD5L deficiency effects. RNA sequencing confirmed PI3K/Akt activation downstream of CD5L. These results define CD5L as an immunometabolic checkpoint that suppresses NF‐κB‐mediated inflammation, suggesting a therapeutic target for AAA.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →